'Tb vaccine' presentation slideshows

TB Vaccines Development

TB Vaccines Development. ASEAN-EU STI Cooperation Meeting Thailand Science Park, Thailand 21 -23 January 2014. JAIME C. MONTOYA, MD, MSc, PhD Coordinator, ASEAN-NDI Secretariat Focal Point for the Philippines, ASEAN Subcommittee on Biotechnology

854 views • 58 slides

Clinical Research Practice

Clinical Research Practice. Clinical Infectious Diseases 2. Objectives. Differentiate between infection and disease. Describe why poor health status makes one more susceptible to infectious disease. Identify routes of transmission for TB, HIV and Malaria.

626 views • 45 slides

Progress in Developing New TB Vaccines Jerald C. Sadoff, MD

Progress in Developing New TB Vaccines Jerald C. Sadoff, MD Reversing the Tide: The End of Tuberculosis Columbia University March 7 th 2006. Potential Impact of 50-90% Effective Vaccines. Vaccines in combination with antibiotics could control the epidemic

403 views • 39 slides

Foundation to facilitate European efforts towards the global development of new TB vaccines

510 views • 38 slides

Hope in the TB Pipeline: Vaccines

Hope in the TB Pipeline: Vaccines. Dr. Michael Brennan Senior Advisor, Global Affairs J2J Lung Health Media Training 42nd Union World Conference on Lung Health Lille, France 27 October 2011. WHO Global Tuberculosis Control 2011 Report.

471 views • 37 slides

From research to clinical trials Brigitte Gicquel Institut Pasteur Coordination of TB ETHICS and

From research to clinical trials Brigitte Gicquel Institut Pasteur Coordination of TB ETHICS and TB VACCINE Cluster of the European Commission. Today, we observe an acceleration in the accumulation of knowledge: An increase of the quantity of knowledge

456 views • 35 slides

ID93/GLA-SE TB Vaccine Candidate

ID93/GLA-SE TB Vaccine Candidate. TB Vaccines Global Forum Cape Town, 26 March 2013. 100 nm oil droplets stabilized by emulsifiers in a bulk aqueous phase - Manufactured by high-shear homogenization - Pre-formed emulsion added to antigen before injection

759 views • 32 slides

Hope in the TB Pipeline II: Vaccines

Hope in the TB Pipeline II: Vaccines. Peg Willingham Aeras Global TB Vaccine Foundation. J2J Lung Health Media Training 41st Union World Conference on Lung Health Berlin, Germany 12 November 2010. Existing TB Vaccine Ineffective. BCG introduced in 1921.

426 views • 26 slides

TB Vaccine Development Update

TB Vaccine Development Update. 16 th Annual Conference of the Union North America Region New Tools Session 24 February 2012 Lew Barker, MD, MPH Aeras. Rockville, MD. WHO Global Tuberculosis Control 2011 Report.

502 views • 26 slides

All images used under US Fair Use for non-profit, educational purposes

All images used under US Fair Use for non-profit, educational purposes. An Introduction to PharmaJet. Swaziland has the highest rate of HIV/AIDS of any country in the world 40% rate of HIV in women ages 15-49 HIV is responsible for 64% of deaths

320 views • 24 slides

Hope in the Pipeline The Search for New TB Vaccines

326 views • 23 slides

Hope in the TB Vaccine Pipeline

Hope in the TB Vaccine Pipeline. Sebastian Gelderbloem Aeras Global TB Vaccine Foundation. 25 January 2011. Aeras Global TB Vaccine Foundation. Mission To develop new, more effective TB vaccines and ensure their availability to all who need them Method

399 views • 21 slides

Stop TB Partnership

WHO Expert Working Group on R&D Financing Stop TB New Tools Working Groups Marcos Espinal Executive Secretary. Stop TB Partnership. What: A global social movement to Stop TB Need for multisectoral approach New opportunities to work in partnership Vision: A TB-free world Mission:

409 views • 18 slides

New approaches in TB diagnosis and treatment

New approaches in TB diagnosis and treatment. Prof. M.A. Tageldin. Why We Need New Tools to Fight TB. New tools are desperately needed to save millions of lives needlessly lost to TB.

311 views • 17 slides

Infectious Conditions of the Lower Respiratory Tract

Infectious Conditions of the Lower Respiratory Tract. Tuberculosis. Supportive Educative Nursing. Etiology. Gram + AFB Exposure repeated Contamination Replication. Statistics. Video. http://www.youtube.com/watch?v=QgVchBERVng. Populations At Risk. Symptoms. Diagnosis.

307 views • 13 slides

Partnerships in TB Vaccine Research & Development

219 views • 13 slides

Totally Drug Resistant TB: The Role of New TB Vaccines

Totally Drug Resistant TB: The Role of New TB Vaccines. Videlis Nduba, MD, MPH Grace Kiringa, MD, MSc KEMRI/CDC Kisumu 8 th World Conference of Science Journalists Helsinki, Finland. Tuberculosis: A Global Epidemic. Estimated number of new cases, 2010.

230 views • 9 slides

Working Group on New Vaccines

Working Group on New Vaccines. Purpose of the Working Group on New Vaccines. Facilitate the development of new, more effective TB vaccine by promoting collaboration and coordination amongst multiple stakeholders Support the objectives for new vaccines as outlined in the Global Plan to Stop TB

239 views • 9 slides

Tuberculosis Vaccine Market - Latest Advancements & Market Outlook 2018 to 2026

Tuberculosis (TB) is a highly contagious disease caused by the bacterium known as Mycobacterium tuberculosis and is mostly spread through person to person contact. It causes multisystem infection and eventually might lead to death of the infected person. Two types of TB that are commonly observed include latent TB in which the infected person do not show symptoms and active TB in which the infected person shows clinical symptoms of TB.

89 views • 8 slides

Considerations on the financing of future TB Vaccine Development

European Investment Bank. Considerations on the financing of future TB Vaccine Development. Thomas C. Barrett TB Vaccines Third Global Forum Cape Town, South Africa 27 March 2013. The Situation So Far.

140 views • 7 slides